Oxidation-Reduction Potential in Patients undergoing Transcatheter or Surgical Aortic Valve Replacement

Table 1

Baseline characteristics. BMI: body mass index; BSA: body surface area; sORP: static oxidation-reduction potential; EuroSCORE: European System for Cardiac Operative Risk Evaluation p < 0.05.

	All patients	SAVR	TAVR	Comparison SAVR vs. TAVR
	n = 72	n = 36	n = 36	p-value; (t-test/Wilcoxon Test/Fisher Test)
Gender (male)	32 (44.4%)	21 (58.3%)	11 (30.6%)	0.0321
Age (years)	77.3 ± 9.2	71.5 ± 8.8	83.0 ± 5.3	<0.0001
Weight (kg)	76.3 ± 18.0	82.1 ± 16.8	70.5 ± 17.5	0.0054
BMI	27.4 ± 5.7	28.4 ± 5.1	26.5 ± 6.2	0.0481
BSA (m^2)	1.9 ± 0.2	2.0 ± 0.2	1.8 ± 0.2	0.0005
Obesity (BMI > 30)	21 (29.2%)	13 (36.1%)	8 (22.2%)	0.2997
Hypertension (yes)	58 (80.6%)	29 (80.6%)	29 (80.6%)	1.0000
Smoker (yes)	7 (9.7%)	5 (13.9%)	2 (5.6%)	0.0254
Nonsmoker but former smoker (yes)	14 (19.4%)	11 (30.6%)	3 (8.3%)
Diabetes mellitus (yes)	28 (38.9%)	15 (41.7%)	13 (36.1%)	0.8092
Chronic renal insufficiency (yes)	13 (18.1%)	2 (5,6%)	11 (30.6%)	0.0120
Logistic EuroScore	16.1 ± 10.3	10.5 ± 9.6	21.7 ± 7.5	<0.0001
sORP baseline [mV]	166.3 (Q1: 142.8; Q3: 178.2)	155.2 (Q1:129.7; Q3: 170.4)	172.1 (Q1: 162; Q3: 179.6)	0.0034
Antioxidant capacity baseline [C]	0.1 (Q1: 0.1; Q3: 0.2)	0.11 (Q1: 0.09; Q3: 0.39)	0.10 (Q1:0.08; Q3: 0.11)	0.0235